Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status.
Lauren K SheaKazuhito HonjoDavid T ReddenEdlue TabengwaRan LiFu-Jun LiMikhail ShakhmatovNicholas ChiorazziRandall S DavisPublished in: Blood cancer journal (2019)
Keyphrases